Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urinary Round Cells Predict Need For Hemodialysis

By LabMedica International staff writers
Posted on 28 Jun 2016
Urinalysis is a safe, easy, and cost-effective diagnostic tool, and sediments are indicative of nephron condition, therefore, it can be considered as a virtual renal biopsy and is useful for the differential diagnosis of acute kidney injury and chronic kidney disease.

Voided urine contains a variety of cells from the kidney and urinary tract and urinalysis provides diverse information when the cellular components are investigated. More...
However, not all cells in the urine have been characterized and the origins of cells have not been determined in some cases.

Scientists at the School of Medicine, The University of Tokyo (Japan) and their colleagues collected spot urine samples from 372 patients, 278 males and 94 females. Male patients were 68.4 years on average, range 30 to 95 years and females were 67.9 years on average, range 26 to 89. A total of 247 cases had diabetes and 125 did not have diabetes were included in the study.

Urine sediments were prepared and examined following a previously defined method. Round cells were counted at 100 × magnification in whole-field (WF) view and scored as negative, 1–4/WF, 5–9/WF, or greater than 10/WF. Serum creatinine estimated at two years and six months before the examination, on the day of examination and six months after the examination were compared with the round cells scores. Urine sediment was prepared for immunohistochemistry using Smear Gell (GenoStaff, Tokyo, Japan) processed and immunofluorescence staining was observed under a fluorescence microscope, BZ-X700 (Keyence, Osaka, Japan). Ribonucleic acid (RNA) extraction and quantitative real-time reverse transcription-polymerase chain reaction were performed on sediment cells, which were also cultured.

The scientists found ‘round cell’ to be distinct from known cells in sediment and is close to proximal convoluted tubule-derived cells based on morphology and molecular marker expression Gamma-Glutamyltransferase 1 (GGT1) but not podocalyxin. Also it was positive for undifferentiated cell markers, including Paired box gene 2 (PAX2), Wilms Tumor 1 (WT1), Odd-Skipped Related Transcription Factor 1(OSR1), and SIX Homeobox 2 (SIX2). They were observed in end-stage renal failure patients and the number of cells was correlated with the severity of chronic kidney disease. A prospective analysis revealed that patients who had more round cells were more likely to require hemodialysis within a year.

The authors concluded that the novel round cell is close to tubular epithelial cells and expresses undifferentiated cell markers. Round cells can be substantially detected in advanced renal failure and could be a novel marker for kidney death within a year for both in diabetic and non-diabetic kidney disease. The study was published on June 1, 2016, in the journal Clinica Chimica Acta.

Related Links:
School of Medicine, The University of Tokyo
GenoStaff
Keyence

Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.